Reuben Notes

Mycological disease of the Nail

Diagnosis

  • Clinical
    • Primary criteria
      • white/yellow or orange/brown patches or streaks
    • Secondary criteria
      • Onycholysis
      • Subungual hyperkeratosis/debris
      • Nail-plate thickening
  • Laboratory
    • Positive microscopic evidence
    • Positive culture of dermatophyte
  • accurate diagnosis can only be made when both clinical and laboratory criteria are present
  • Poor prognositc factorssher
    • Area of nail involvment >50%
    • Significant lateral disease
    • Subungual hyperkeratosis >2 mm
    • White/yelow or orange/brown streaks in nail (includes dermatophytoma)
    • Total dystrophic onychomycosis (with matirx involvement)
    • Nonresponsive organisms (eg, Scytalidium mold)
    • Patients with immunosuppression
    • Diminished peripheral circulation
  • Nail changes can be nonspecific
    • Onycholysis
      • May result from trauma
      • Psoriasis
    • Subungual hyperkeratosis
      • Psoriasis
    • Nail-plate thickening
      • trauma
      • onychogryphosis
      • Lichen planus
      • psoriasis
  • Changes likely unrelated to onychomycosis
    • Longitudinal or transverse ridges
    • pits
    • onychoschia
    • dryness
  • Differential Diagnosis
    • Psoriasis
    • Neoplasms
    • Lichen Planus

Treatment

  • Topicals
    • Ciclopirox nail lacquer has only a 5.5% to 8.5% cure rate and a recurrence rate of 25% - 50% at 60 weeks
      • Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol 2000; 43(suppl)S70-80
  • Oral meds
    • Dose therapy
    • Warshaw E, Fett D; Pulse Versus Continuous Terbinafine for Onychomycosis: A Randomized, Double-blind, controlled trial; J Am Acad Dermatol; Oct 2005, Vol 53(4); 578-584
      • standard, continuous therapy shown to be superior to pulse therapy
        • continuous dose group recieved 250mg daily for 3 months
        • Pulse dose group recieved 500mg daily for 1 week per month for 3 months
      • Cure rate of all 10 nails
        • Continuous therapy group - 25%
        • Pulsed therapy group - 15%
      • 125mg terbinafine for 6 months reported to have a 89% rate of negative mycology at 6 months
        • Matsumoto T, Tanuma H, Kaneko S, Takasu H, Nishiyama S. Clinical and pharmacokinetic investigations of oral terbinafine in patients with tinea unguium. Mycoses 1995;38:135-44
    • 26 published clinical studies for oral treatment show only 25% - 50% complete cure rate
      • Epstein E. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. Arch Dermatol 1998;134:1551-4
    • FDA reports only a 14% - 38% complete cure rate for approved oral agents
  • Surgical
    • Anectodal evidence suggests combination of avulsion and oral therapy (for more than 3 months), may acheive higher cure rates
      • may be useful especially in nails with clinical patterns which are typically more resistant
        • extensive onychauxis
        • lateral pattern
        • longitudinal spike
        • severe onycholysis
        • dermatophytoma
      • McInnes BD, Dockery GL. Surgical treatment of mycotic toenails. J Am Podiatr Med Assoc 1997;87:557-64
      • Gupta AK, Baran R, SummerbellR. Onychomycosis: Strategies to improve efficacy and reduce recurrence. J Eur Acad Dermatol Venereol 2002;16:579-86
  • Practical Considerations
    • Mycological cure signifies that the funtal infection has been successfully treated, however pt must understand at beginning of therapy that they will likely not have a 100% normal nail. Some residual changes will be present.
    • recurrence reported as high as 53%

References

  • Sher RK, Tavakkol A. Onychomycosis: Diagnosis and definition of cure. J Am Acad Dermatol June 2007;56(6):939-44